Concepedia

Melanoma Progression

Melanoma Progression is a biological process denoting the sequential development and advancement of melanocytic tumors from benign or in situ states to increasingly aggressive, invasive, and metastatic malignancies characterized by accumulated genetic, epigenetic, and microenvironmental alterations.

5.9K

Publications

457.9K

Citations

29.1K

Authors

4.4K

Institutions

Publications per year

2017–2026

1.9K

Parents

Publications

5.9K

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text

, , +12

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text

, , +17

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.4K citations · Full text

, , +17

Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation

Caroline Robert, Georgina V. Long, Benjamin Brady et al. · New England Journal of Medicine · 2014 · 5.4K citations · Full text

, , +14

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2019 · 3.7K citations · Full text

, , +14

1–5 of 5.9K

Authors

29.1K

  1. DS
    Dirk Schadendorf

    Heidelberg University, Germany

    137 publications · 59.7K citations

    69

    h-index

  2. RD
    Reinhard Dummer

    University Hospital of Zurich, Switzerland

    113 publications · 29.9K citations

    63

    h-index

  3. MH
    Meenhard Herlyn

    The Wistar Institute, United States

    96 publications · 12.4K citations

    58

    h-index

  4. GV
    Georgina V. Long

    The University of Sydney, Australia

    97 publications · 39K citations

    55

    h-index

  5. CR
    Caroline Robert

    Institut Gustave Roussy, France

    88 publications · 48.5K citations

    52

    h-index

1–5 of 29.1K

Institutions

4.4K

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    79 h-index

    977 publications

    177.7K citations

  2. Harvard University

    Cambridge, United States

    75 h-index

    720 publications

    166.8K citations

  3. Massachusetts General Hospital

    Boston, United States

    74 h-index

    507 publications

    83.1K citations

  4. Inserm

    Paris, France

    70 h-index

    1.1K publications

    113.9K citations

  5. Memorial Sloan Kettering Cancer Center

    New York, United States

    70 h-index

    586 publications

    127.8K citations

  6. Dana-Farber Cancer Institute

    Boston, United States

    69 h-index

    473 publications

    167K citations

  7. Melanoma Institute Australia

    Sydney, Australia

    69 h-index

    536 publications

    105.5K citations

  8. The University of Sydney

    Sydney, Australia

    68 h-index

    591 publications

    100.2K citations

1–8 of 4.4K

Venues

  1. PubMed

    Repository · 392 publications · 28.2K citations

    96

    h-index

  2. Cancer Research

    161 publications · 18.7K citations

    79

    h-index

  3. Journal of Investigative Dermatology

    JID · 228 publications · 14.4K citations

    65

    h-index

  4. Oncogene

    124 publications · 9K citations

    59

    h-index

  5. International Journal of Cancer

    146 publications · 10K citations

    58

    h-index

1–5